Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology

被引：0

作者：

Kerle, Irina A. ^{[1
,2
,3
,4
,5
,6
]}

Gross, Thomas ^{[2
,3
,7
]}

Koegler, Anja ^{[2
,3
,7
]}

Arnold, Jonas S. ^{[2
,3
,8
,9
,10
,11
,12
,13
,14
]}

Werner, Maximilian ^{[1
,2
,3
,4
,5
,6
]}

Eckardt, Jan-Niklas ^{[15
,16
]}

Moehrmann, Elena E. ^{[1
,2
,3
,4
,5
,6
]}

Arlt, Marie ^{[2
,3
,8
,9
,10
,11
,12
,13
,14
]}

Hutter, Barbara ^{[17
,18
]}

Huellein, Jennifer ^{[17
,18
]}

Richter, Daniela ^{[1
,4
,5
,19
]}

Schneider, Martin M. K. ^{[15
]}

Hlevnjak, Mario ^{[17
,18
]}

Moehrmann, Lino ^{[1
,2
,3
,4
,5
,6
]}

Hanf, Dorothea ^{[1
,2
,3
,4
,5
,6
]}

Heilig, Christoph E. ^{[20
,21
,22
]}

Kreutzfeldt, Simon ^{[20
,21
]}

Teleanu, Maria-Veronica ^{[20
,21
,22
]}

Schroeck, Evelin ^{[2
,3
,7
,8
,9
,10
,11
,12
,13
,14
]}

Huebschmann, Daniel ^{[17
,18
,23
,24
,25
]}

Horak, Peter ^{[20
,21
]}

Heining, Christoph ^{[1
,2
,3
,4
,5
,6
]}

Froehling, Stefan ^{[20
,21
,23
,26
]}

Glimm, Hanno ^{[1
,2
,3
,4
,5
,6
,19
]}

机构：

[1] UCC, Fac Med, Natl Ctr Tumor Dis Dresden NCT, DKFZ,Dept Translat Med Oncol, Dresden, Germany

[2] Univ Hosp Carl Gustav Carus, TUD Dresden Univ Technol, Dresden, Germany

[3] Helmholtz Zentrum Dresden Rossendorf HZDR, Dresden, Germany

[4] Univ Hosp Carl Gustav Carus, Fac Med, Translat Med Oncol, Dresden, Germany

[5] Univ Hosp Carl Gustav Carus, TUD Dresden Univ Technol, Dresden, Germany

[6] German Canc Consortium DKTK Partner Site Dresden, Partner Site Dresden, Dresden, Germany

[7] UCC, Fac Med, Natl Ctr Tumor Dis NCT, German Canc Res Ctr DKFZ,Core Unit Mol Tumor Diagn, Dresden, Germany

[8] Univ Hosp Carl Gustav Carus, TUD Dresden Univ Technol, Inst Clin Genet, Dresden, Germany

[9] TUD Dresden Univ Technol, Fac Med, Dresden, Germany

[10] Hereditary Canc Syndrome Ctr Dresden, ERN GENTURIS, Dresden, Germany

[11] UCC Dresden, Fac Med, Natl Ctr Tumor Dis Dresden NCT, German Canc Res Ctr DKFZ,NCT, Dresden, Germany

[12] German Canc Consortium DKTK, Dresden, Germany

[13] German Canc Res Ctr, Heidelberg, Germany

[14] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany

[15] Univ Hosp Carl Gustav Carus Dresden, Dept Internal Med 1, Dresden, Germany

[16] Tech Univ Dresden, Else Kroner Fresenius Ctr Digital Hlth, Dresden, Germany

[17] NCT Heidelberg, Mol Precis Oncol Program, Computat Oncol Grp, Heidelberg, Germany

[18] DKFZ, Heidelberg, Germany

[19] German Canc Res Ctr DKFZ Heidelberg, Div Appl Funct Genom, Heidelberg, Germany

[20] Natl Ctr Tumor Dis NCT Heidelberg, Div Translat Med Oncol, Heidelberg, Germany

[21] German Canc Res Ctr, Heidelberg, Germany

[22] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany

[23] German Canc Consortium DKTK, Heidelberg, Germany

[24] DKFZ, Bioinformat & Precis Med BPM, Innovat & Serv Unit, Heidelberg, Germany

[25] Heidelberg Inst Stem Cell Technol & Expt Med, HI STEM, Heidelberg, Germany

[26] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany

来源：

NPJ PRECISION ONCOLOGY | 2025年 / 9卷 / 01期

关键词：

DROSOPHILA-MELANOGASTER; CANCER; PROGRAM; REPAIR; GENE;

D O I：

10.1038/s41698-024-00788-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Precision oncology offers new cancer treatment options, yet sequencing methods vary in type and scope. In this study, we compared whole-exome/whole-genome (WES/WGS) and transcriptome sequencing (TS) with broad panel sequencing by resequencing the same tumor DNA and RNA as well as normal tissue DNA for germline assessment, from 20 patients with rare or advanced tumors, who were originally sequenced by WES/WGS +/- TS within the DKFZ/NCT/DKTK MASTER program from 2015 to 2020. Molecular analyses resulted in a median number of 2.5 (gene panel) to 3.5 (WES/WGS +/- TS) treatment recommendations per patient. Our results showed that approximately half of the therapy recommendations (TRs) of both sequencing programs were identical, while approximately one-third of the TRs in WES/WGS +/- TS relied on biomarkers not covered by the panel. Eight of 10 molecularly informed therapy implementations were supported by the panel, the remaining two were based on biomarkers absent from the panel, highlighting the potential additional clinical benefit of WGS and TS.

引用

页数：10

共 50 条

[21] Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC
Li, Lei
Bao, Hainan
Xu, Yawei
Yang, Wuping
Zhang, Zedan
Ma, Kaifang
Zhang, Kenan
Zhou, Jingcheng
Gong, Yanqing
Ci, Weimin
Gong, Kan
MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (06) : 741 - 752
[22] Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?
Winkler, Eva C.
Wiemann, Stefan
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (12) : 1259 - 1270
[23] Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging
Hou, Ying-Chen Claire
Yu, Hung-Chun
Martin, Rick
Cirulli, Elizabeth T.
Schenker-Ahmed, Natalie M.
Hicks, Michael
Cohen, Isaac V.
Jonsson, Thomas J.
Heister, Robyn
Napier, Lori
Swisher, Christine Leon
Dominguez, Saints
Tang, Haibao
Li, Weizhong
Perkins, Bradley A.
Barea, Jaime
Rybak, Christina
Smith, Emily
Duchicela, Keegan
Doney, Michael
Brar, Pamila
Hernandez, Nathaniel
Kirkness, Ewen F.
Kahn, Andrew M.
Venter, J. Craig
Karow, David S.
Caskey, C. Thomas
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (06) : 3053 - 3062
[24] Comparison of Antimicrobial Resistance and Pan-Genome of Clinical and Non-Clinical Enterococcus cecorum from Poultry Using Whole-Genome Sequencing
Sharma, Poonam
Gupta, Sushim K.
Barrett, John B.
Hiott, Lari M.
Woodley, Tiffanie A.
Kariyawasam, Subhashinie
Frye, Jonathan G.
Jackson, Charlene R.
FOODS, 2020, 9 (06)
[25] Construction of complete Tupaia belangeri transcriptome database by whole-genome and comprehensive RNA sequencing
Sanada, Takahiro
Tsukiyama-Kohara, Kyoko
Shin-I, Tadasu
Yamamoto, Naoki
Kayesh, Mohammad Enamulo Hque
Yamane, Daisuke
Takano, Jun-ichiro
Shiogama, Yumiko
Yasutomi, Yasuhiro
Ikeo, Kazuho
Gojobori, Takashi
Mizokami, Masashi
Kohara, Michinori
SCIENTIFIC REPORTS, 2019, 9 (1)
[26] Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities
Arai, Roberto Jun
Guindalini, Rodrigo Santa Cruz
Llera, Andrea Sabina
O'Connor, Juan Manoel
Muller, Bettina
Lema, Mauricio
Freitas, Helano C.
Soria, Tannia
Delgado, Luca
Landaverde, Denis
Montenegro, Paola
Riechelman, Rachel P.
ONCOLOGIST, 2019, 24 (08) : E709 - E719
[27] Identifying barriers and opportunities to facilitate the uptake of whole genome sequencing in paediatric haematology and oncology practice
Bishop, Michelle
Vedi, Aditi
Bowdin, Sarah
Armstrong, Ruth
Bartram, Jack
Bentley, David
Ross, Mark
Hook, C. Elizabeth
Yin Chung, Brian Hon
Moss, Parker
Rowitch, David H.
Tarpey, Patrick
Behjati, Sam
Murray, Matthew J.
BMC MEDICAL EDUCATION, 2024, 24 (01)
[28] RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing
Hu, Xueda
Wan, Shengqing
Ou, Ying
Zhou, Boping
Zhu, Jialou
Yi, Xin
Guan, Yanfang
Jia, Wenlong
Liu, Xing
Wang, Qiudao
Qi, Yao
Yuan, Qing
Huang, Wanqiu
Liao, Weijia
Wang, Yun
Zhang, Qinghua
Xiao, Huasheng
Chen, Xinchun
Huang, Jian
CANCER LETTERS, 2015, 357 (02) : 510 - 519
[29] Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology
Bartha, Aron
Gyorffy, Balazs
CANCERS, 2019, 11 (11)
[30] NyuWa Genome resource: A deep whole-genome sequencing-based variation profile and reference panel for the Chinese population
Zhang, Peng
Li, Yanyan
Luo, Huaxia
Wang, You
Wang, Jiajia
Zheng, Yu
Niu, Yiwei
Shi, Yirong
Zhou, Honghong
Song, Tingrui
Kang, Quan
Xu, Tao
He, Shunmin
CELL REPORTS, 2021, 37 (07):

← 1 2 3 4 5 →